APOTEX INC. v MERCK CANADA INC. and MERCK FROSST CANADA & CO., 2012 FC 1418 (Alendronate*)
Justice Hughes - 2012-12-04
Read full decision. Automatically generated summary:
These Reasons and Judgment are further to those dated October 24, 2012 (cited as 2012 FC 1235) wherein I provided a number of determinations as to matters in dispute in the expectation that the parties, with the aid of their accounting experts, could arrive at a final figure representing the amount of compensation, together with pre-judgment interest, that the Court would award to the Plaintiff Apotex in this action arising from section 8 of the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133.
Decision relates to: